Visit any leading European technical university, and you will find an extensive portfolio of patented hardware innovations. The university has invested heavily in securing the intellectual property. The academic papers have been published in top-tier journals. The Principal Investigator (PI) has fulfilled the basic requirements of their grant’s "Knowledge Utilization" clause.
And yet, the technology never reaches the market.
This is the Status Quo of deep tech commercialization. When institutions recognize that a specialized physical instrument is incompatible with the high-friction, venture-backed spin-off model, they frequently default to a passive strategy. The innovation becomes a stranded asset, trapped between a theoretical legal framework and a decaying physical prototype.
The "Patent & Pray" Fallacy
The most common manifestation of this status quo is the "Patent & Pray" strategy.
When a piece of novel hardware—such as a highly specialized single nanoparticle deposition system—demonstrates commercial potential, the Tech Transfer Office (TTO) rushes to secure the foreground IP. The assumption is that once the patent is filed, a major legacy distributor or industrial player will discover the patent, recognize its brilliance, and immediately license the technology for a lucrative royalty fee.
In the realm of physical scientific instruments, this rarely happens.
Major industrial players are not in the business of basic hardware R&D. They want to acquire de-risked, TRL 8/9 assets. They want a CE-marked product with an established supply chain and a proven user interface. They look at a university's patent for a TRL 4 "duct-tape and LabVIEW" prototype and see millions of euros in un-funded "Platform Tax" (the engineering required to make it commercially viable).
Because the university is not equipped to bridge this engineering gap, the major distributors walk away. The patent sits in a filing cabinet, generating maintenance fees rather than royalties.
The Evaporation of Tacit Knowledge
While the TTO waits for a licensing deal that will never materialize, a second, more fatal countdown is occurring in the lab.
An academic bench prototype is not a self-sustaining machine; it is inextricably linked to its creator. The PhD candidate or postdoc who spent four years designing the optical path, writing the custom scripts, and calibrating the sensors holds the tacit knowledge required to make the instrument function.
Eventually, that researcher graduates. Because the ecosystem lacks structured commercialization pathways that don't involve the immense financial risk of a VC spin-off, the researcher leaves the lab. They take their specialized engineering talent to an entirely different industry.
The moment they walk out the door, the tacit knowledge evaporates. The prototype breaks down during the next experiment, and because no one else knows how to fix the bespoke wiring, the instrument is pushed to the back of the bench. The patented IP is effectively dead because the human capital required to execute it is gone.
Moving from Passive to Active Valorisation
A patent is a legal firewall, not a commercialization strategy. We must stop treating the filing of IP as the finish line of the valorisation process.
To break the status quo and rescue abandoned IP, universities and TTOs must adopt an active commercialization framework. If a technology is too niche for venture capital but too raw for a legacy distributor, it requires a dedicated execution engine.
By licensing these stranded assets to centralized productization studios, institutions can bypass the "Patent & Pray" trap. The studio provides the missing engineering infrastructure—the standardized Python/PyQt architecture, the CE-compliant modular enclosures, and the supply chain.
More importantly, it provides a structured career pathway to hire the graduating researcher, preserving the tacit knowledge and actively transforming a dormant patent into a globally deployable scientific instrument.